ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974